ORIX CORP — Director's Dealing 2012

Jun 15, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Sucampo Pharmaceuticals, Inc. (SCMP)
CIK: 0001365216
Period of Report: 2007-08-02

Reporting Person: ORIX CORP (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	782916	Indirect
Class A Common Stock	1198796	Indirect

Footnotes

F1: ORIX Corporation indirectly beneficially owns the shares as a limited partner of OPE Limited Partnership 1.

F2: ORIX Corporation indirectly beneficially owns the shares as a limited partner of OPE Limited Partnership 2.